Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Prostate Cancer

Prostate Cancer

Find a Physician


Quickly search our world-class physicians and faculty by keyword, location and insurance provider.


Prostate Cancer

WCM Urology Post-Doc Named Prostate Cancer Foundation Young Investigator

Michael Augello, Ph.D. was named as a recipient of the Prostate Cancer Foundation's 2017 Young Investigator Awards. Dr. Augello is a post-doc working with Dr. Christopher Barbieri in Urology at Weill Cornell Medicine. Learn more here about prostate cancer research at Weill Cornell Medicine.

Prostate Cancer Foundation Announces 2017 Young Investigator Awards Recipients

Prostate Cancer Partial Gland Ablation - Webinar with Dr. Jim C. Hu

Jim C. Hu, M.D., M.P.H. discusses various minimally-invasive and non-surgical treatment options under the umbrella term of partial gland ablation.

Dr. Hu speaks about techniques & practical outcomes of various partial ablation procedures performed for men with prostate cancer, most notably the High Intensity Focused Ultrasound (HIFU) procedure, which is performed at Weill Cornell Medicine.

PSMA radioligand therapy shows promise in clinical study

Therapeutic agent developed by Neil Bander, MD, Weill Cornell Urology Physician Scientist, shows promise in new trials to provide treatment for advanced prostate cancer.


Incidence of Metastatic Prostate Cancer in Older Men Increases Following Drop in PSA Screening

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011, according to new research from Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine prostate-specific antigen (PSA) testing.

Incidence of metastatic prostate cancer has increased among older men as PSA screening declines (With Dr. Jim C. Hu)

The incidence of metastatic prostate cancer appears to be rising in men aged 75 years or older, according to results of a SEER analysis published in JAMA Oncology.

This increase may be linked to the U.S. Preventive Services Task Force (USPSTF) 2008 recommendation against routine PSA screenings in men aged 75 years or older and the 2012 recommendation against routine PSA screening regardless of age.


Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.